Search Constraints
Search Results
Select an image to start the slideshow
Risk Stratification for Overall Survival among Metastatic Prostate Cancer Patients Treated by ADT as the First Line Treatment
1 of 5
Biomarker-driven Phase 2 study of Nivolumab in Advanced Metastatic NSCLC
2 of 5
A landscape of treatment options and survivorship for non-small cell lung cancer by Stage and Age.
3 of 5
Assessment of diagnostic accuracy after biomarker combination in the same study: The issue of over-optimism and potential solutions
4 of 5
Evaluation of Propensity Score Matching Techniques on Overall Survival using the National Cancer Data Base
5 of 5